143 related articles for article (PubMed ID: 36229841)
1. Overall survival of individuals with metastatic cancer in Sweden: a nationwide study.
Bütepage G; Carlqvist P; Jacob J; Toft Hornemann A; Vertuani S
BMC Public Health; 2022 Oct; 22(1):1913. PubMed ID: 36229841
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.
Zebrowska K; Banuelos RC; Rizzo EJ; Belk KW; Schneider G; Degeling K
Front Pharmacol; 2023; 14():1249998. PubMed ID: 38074129
[No Abstract] [Full Text] [Related]
3. Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study.
Valachis A; Carlqvist P; Ma Y; Szilcz M; Freilich J; Vertuani S; Holm B; Lindman H
Br J Cancer; 2022 Sep; 127(4):720-725. PubMed ID: 35597870
[TBL] [Abstract][Full Text] [Related]
4. Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer.
Osterlund E; Glimelius B
Acta Oncol; 2022 Oct; 61(10):1278-1288. PubMed ID: 36152023
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
6. The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers.
Rossi A; Torri V; Garassino MC; Porcu L; Galetta D
Cancer Treat Rev; 2014 May; 40(4):485-94. PubMed ID: 24112813
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Planning for return to work during the first year after breast cancer metastasis: A Swedish cohort study.
Johnsson A; Kiani NA; Gernaat SAM; Wilking U; Shabo I; Hedayati E
Cancer Med; 2023 May; 12(9):10840-10850. PubMed ID: 36880198
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes - an observational cohort study in Sweden.
Lindman H; Wiklund F; Andersen KK
BMC Cancer; 2022 Sep; 22(1):1006. PubMed ID: 36138404
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
13. Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry.
Valachis A; Carlqvist P; Szilcz M; Freilich J; Vertuani S; Holm B; Lindman H
Acta Oncol; 2021 Dec; 60(12):1604-1610. PubMed ID: 34549678
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.
Karve SJ; Price GL; Davis KL; Pohl GM; Smyth EN; Bowman L
BMC Health Serv Res; 2014 Nov; 14():555. PubMed ID: 25392276
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.
Marshall EM; Bertaut A; Desmoulins I; Darut-Jouve A; Ponnelle T; Poillot ML; Beltjens F; Arveux P
Breast J; 2017 Mar; 23(2):138-145. PubMed ID: 27935232
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer.
Sorbye H; Cvancarova M; Qvortrup C; Pfeiffer P; Glimelius B
Ann Oncol; 2013 Sep; 24(9):2354-60. PubMed ID: 23704193
[TBL] [Abstract][Full Text] [Related]
18. Clinical landscape of cancer metastases.
Riihimäki M; Thomsen H; Sundquist K; Sundquist J; Hemminki K
Cancer Med; 2018 Nov; 7(11):5534-5542. PubMed ID: 30328287
[TBL] [Abstract][Full Text] [Related]
19. Types of second primary cancer influence overall survival in cutaneous melanoma.
Zheng G; Chattopadhyay S; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
BMC Cancer; 2021 Oct; 21(1):1123. PubMed ID: 34663263
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survival and Cure in Distant Metastatic Breast Cancer.
Güth U; Elfgen C; Montagna G; Schmid SM
Oncology; 2019; 97(2):82-93. PubMed ID: 31055570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
